C57BL/6 Mouse Thymus Epithelial Cells

Cat.No.: CSC-C9086J

Species: Mouse

Source: Thymus

Cell Type: Epithelial Cell

  • Specification
  • Background
  • Scientific Data
  • Q & A
  • Customer Review
Cat.No.
CSC-C9086J
Description
C57BL/6 Mouse Thymus Epithelial Cells from Creative Bioarray are isolated from thymus tissue of pathogen-free laboratory mice. C57BL/6 Mouse Thymus Epithelial Cells are grown in a T25 tissue culture flask pre-coated with gelatin-based coating solution for 2 min and incubated in Creative Bioarray’s Culture Complete Growth Medium for 3-5 days. Cells are detached from flasks and immediately cryo-preserved in vials. Each vial contains at least 0.5x10^6 cells per ml and is delivered frozen. Cells can be expanded for 3-7 passages at a split ratio of 1:2 under the cell culture conditions specified by Creative Bioarray. Repeated freezing and thawing of cells is not recommended.
Species
Mouse
Source
Thymus
Recommended Medium
Complete Epithelial Cell Medium
Cell Type
Epithelial Cell
Disease
Normal
Storage and Shipping
We ship frozen cells on dry ice. Upon receiving, directly and immediately transfer the cells from dry ice to liquid nitrogen and keep the cells in liquid nitrogen until they are needed for experiments. Never can primary cells be kept at -20 °C.
Citation Guidance
If you use this products in your scientific publication, it should be cited in the publication as: Creative Bioarray cat no. If your paper has been published, please click here to submit the PubMed ID of your paper to get a coupon.

C57BL/6 mouse thymus epithelial cells (TECs) are specialized stromal cells derived from the thymus of the widely recognized C57BL/6 inbred strain. They form the structural framework of the thymic microenvironment and are indispensable for T‑cell development, differentiation, and central immune tolerance. TECs are subclassified into cortical TECs (cTECs) and medullary TECs (mTECs), which orchestrate positive and negative selection of thymocytes, respectively, via MHC presentation, cytokine secretion, and expression of autoimmune regulator (AIRE).

The C57BL/6 genetic background provides exceptional advantages for translational and commercial applications: well‑characterized genome, low inter‑individual variability, robust immune responses, and extensive prior validation in immunology, oncology, and regenerative medicine. Primary TECs from this strain exhibit high functional fidelity, consistency, and batch‑to‑batch reproducibility-critical attributes for drug screening, thymus‑on‑a‑chip models, regenerative therapy development, and autoimmune disease research.

Offered as cryopreserved, high‑viability preparations, C57BL/6 mouse TECs enable reliable in vitro modeling of thymopoiesis, testing of immunomodulatory compounds, and scalable production of thymic organoids. Their superior purity, defined phenotype (EpCAM+, cytokeratin+, and AIRE+ for mTECs), and retained biological activity support robust experimental outcomes, reducing animal usage and accelerating preclinical discovery. These cells represent a premium tool for immune‑centered drug discovery, toxicology, and cell therapy platforms.

TEC-Derived FGF21 Protects Against Thymic Aging

Age-related thymic involution precedes aging of all other organs in vertebrates and initiates the process of declining T cell diversity, which leads to eventual immune dysfunction. Whether FGF21, a liver-derived pro-longevity hormone that is also produced in thymic stroma, including by adipocytes, controls the mechanism of thymic demise is incompletely understood.

Here, Youm, YH. et al. demonstrate that elevation of FGF21 in thymic epithelial cells (TECs) and in adipocytes protects against thymic aging, whereas conditional hepatic overexpression did not impact thymic biology in aged mice. Notably, elevation of thymic FGF21 increased naïve CD8 T cells in aged animals and extended healthspan. Mechanistically, thymic FGF21 overexpression elevated TECs and reduced fibroadipogenic cells. Ablation of β-klotho, the obligatory co-receptor for FGF21 in Foxn1+ TECs, accelerated thymic aging, suggesting regulation of TECs by FGF21 is partially required for thymic lymphopoiesis. These findings establish that paracrine FGF21 improves thymic function and delays immune aging.

a, Strategy for generation of TEC-specific FGF21 transgenic mice. b, Representative hematoxylin and eosin (H&E) histology images of thymus in 24-month-old mice. c, Expression of FGF21 in TECs of control and Foxn1Cre-FGF21Tg-overexpressing mice. d-g, Characterization of thymic involution of aged mice. h, FACS quantification, frequencies and numbers of naive (CD62L+CD44-) and E/M (CD62L-CD44+) T cells in spleen of 24-month-old control and iFGF21-FoxN1Cre mice.

Fig. 1. Thymic epithelial specific FGF21 overexpression protects against thymic aging (Youm, Yun-Hee, et al., 2025).

Ask a Question

Write your own review

For research use only. Not for any other purpose.

Hot Products